RESOURCES

Blog

Antigen-Specific T Cells to MUC-1 Antigen

Antigen-Specific T Cells to MUC1 Antigen   Our scientists were among the first to develop custom antigen-specific T cells for research use and have created them against a diverse range of targets, including viral, tumor, and self-antigens. We’re now developing the next generation of antigen-specific T cells to target some of today’s most prevalent and…

Read more

Irradiated PBMC as Research Tool | Ignyte Bio

Irradiated PBMC as Research Tools Irradiated PBMC are PBMC from normal donors that have been subjected to high frequency ionizing X-Ray or gamma radiation. This exposure creates DNA damage that prevents certain cells (e.g., T cells, NK cells, B cells) from undergoing cell division. Irradiated PBMC components retain cellular functions, such as cytokine secretion, cytotoxicity,…

Read more

FAQs on Using Dendritic Cells for Immuno-oncology and Autoimmunity Research and Development

FAQs on Using Dendritic Cells for Immuno-oncology and Autoimmunity Research and Development Dendritic cells are a family of immune cells that help to maintain balance in the immune system. The dendritic cell family is typically divided into four subgroups: Conventional dendritic cells (DC1 and DC2) Plasmacytoid dendritic cells Inflammatory dendritic cells Langerhans cells Dendritic cells…

Read more

Seasoned Life Sciences Team Launches Ignyte Bio To Speed Therapeutics Discovery

Seasoned Life Sciences Team Launches Ignyte Bio To Speed Therapeutics Discovery Seattle biomaterials company specializes in human immune cell products and biopharma consulting services SEATTLE – (BUSINESS WIRE) –September 13, 2022 – Spurred by the pharmaceutical industry’s demand for immune cells for specialized therapeutic research, four biomaterials leaders have launched Ignyte Bio. The leadership team…

Read more